Diabetes
EMPA1C M
Metformin HCl + Empagliflozin extended-release combination for type 2 diabetes
Dosage Form
Extended-Release Tablets
Packaging
Strip of 10 tablets (10 strips per box)
Composition
Metformin HCl 1000mg + Empagliflozin 25mg (Extended-Release)
Product Highlights
- Dual-action combination: Metformin + Empagliflozin
- Extended-release formulation for once-daily dosing
- Improves glycemic control in type 2 diabetes
- Prescription-only medicine (Rx)
- 14 tablets per pack
Description
EMPA1C-M is a fixed-dose combination of Metformin Hydrochloride 1000 mg and Empagliflozin 25 mg in an extended-release formulation, used for the management of type 2 diabetes mellitus. Metformin works by decreasing hepatic glucose production and improving insulin sensitivity, while Empagliflozin (an SGLT2 inhibitor) helps lower blood glucose by promoting urinary glucose excretion. This dual-action combination offers comprehensive glycemic control in a single once-daily extended-release tablet, improving patient compliance. This is a prescription-only medicine (Rx) and should be used strictly under medical supervision.
